Literature DB >> 6379463

Report of the conference on uses and possible abuses of biosynthetic human growth hormone.

L E Underwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6379463     DOI： 10.1056/NEJM198408303110925

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Growth retardation: an approach to management.

Authors:  R G McArthur
Journal:  Can Fam Physician       Date:  1985-05       Impact factor: 3.275

Review 2.  Growth hormone therapy in Canada: end of one era and beginning of another.

Authors:  H J Dean; H G Friesen
Journal:  CMAJ       Date:  1986-08-15       Impact factor: 8.262

Review 3.  The disability of short stature.

Authors:  C M Law
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

4.  Treatment of short stature in renal disease with recombinant human growth hormone.

Authors:  L Rees; S P Rigden; G Ward; M A Preece
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

5.  Effect of growth hormone on short normal children.

Authors:  P C Hindmarsh; C G Brook
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

6.  Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone.

Authors:  B Tedeschi; G L Spadoni; M L Sanna; P Vernole; D Caporossi; S Cianfarani; B Nicoletti; B Boscherini
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

7.  Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis.

Authors:  W Schmidt; S Doré; A Hilgendorf; S Strauch; R Gareau; G R Brisson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

Review 8.  GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy.

Authors:  Martin O Savage; Helen L Storr
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-10       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.